Emmanuel Hui - CEO - TIGER JADE PEBBLE ACCELERATOR

Emmanuel Hui is the CEO of the Tiger Jade Pebble Accelerator (“Pebble”), a USD early-stage investment company ultimately backed by Tigermed (HKEX:3347) — China’s largest clinical research organisation. Mr. Hui sits on many boards, most notably Opharmic, Tonisity China, and the Hong Kong Hospital Authority Central Institutional Review Board (Paediatrics).

Prior to Pebble, Mr. Hui oversaw all healthcare and life science exposure for Sagamore - a China-only private equity platform; and before that he was the co-founding CEO of Moogene (KRX:622970), a gene therapy company that he started as a Senior Fellow at Dartmouth.